Bandaranayake RM - Search Results

1

Molecular Basis for Drug Resistance in HIV-1 Protease.

Ali A, Bandaranayake RM, Cai Y, King NM, Kolli M, Mittal S, Murzycki JF, Nalam MNL, Nalivaika EA, Özen A, Prabu-Jeyabalan MM, Thayer K, Schiffer CA. Ali A, et al. Among authors: bandaranayake rm. Viruses. 2010 Nov;2(11):2509-2535. doi: 10.3390/v2112509. Epub 2010 Nov 12. Viruses. 2010. PMID: 21994628 Free PMC article.

2

The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.

Bandaranayake RM, Kolli M, King NM, Nalivaika EA, Heroux A, Kakizawa J, Sugiura W, Schiffer CA. Bandaranayake RM, et al. J Virol. 2010 Oct;84(19):9995-10003. doi: 10.1128/JVI.00505-10. Epub 2010 Jul 21. J Virol. 2010. PMID: 20660190 Free PMC article.

3

Extreme entropy-enthalpy compensation in a drug-resistant variant of HIV-1 protease.

King NM, Prabu-Jeyabalan M, Bandaranayake RM, Nalam MN, Nalivaika EA, Özen A, Haliloğlu T, Yilmaz NK, Schiffer CA. King NM, et al. Among authors: bandaranayake rm. ACS Chem Biol. 2012 Sep 21;7(9):1536-46. doi: 10.1021/cb300191k. Epub 2012 Jul 2. ACS Chem Biol. 2012. PMID: 22712830 Free PMC article.

4

Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease.

Ragland DA, Nalivaika EA, Nalam MN, Prachanronarong KL, Cao H, Bandaranayake RM, Cai Y, Kurt-Yilmaz N, Schiffer CA. Ragland DA, et al. Among authors: bandaranayake rm. J Am Chem Soc. 2014 Aug 27;136(34):11956-63. doi: 10.1021/ja504096m. Epub 2014 Aug 18. J Am Chem Soc. 2014. PMID: 25091085 Free PMC article.

5

Structural analysis of human immunodeficiency virus type 1 CRF01_AE protease in complex with the substrate p1-p6.

Bandaranayake RM, Prabu-Jeyabalan M, Kakizawa J, Sugiura W, Schiffer CA. Bandaranayake RM, et al. J Virol. 2008 Jul;82(13):6762-6. doi: 10.1128/JVI.00018-08. Epub 2008 Apr 23. J Virol. 2008. PMID: 18434392 Free PMC article.

6

Noble metals strip peptides from class II MHC proteins.

De Wall SL, Painter C, Stone JD, Bandaranayake R, Wiley DC, Mitchison TJ, Stern LJ, DeDecker BS. De Wall SL, et al. Nat Chem Biol. 2006 Apr;2(4):197-201. doi: 10.1038/nchembio773. Epub 2006 Feb 26. Nat Chem Biol. 2006. PMID: 16505807

7

New insights into the structure and function of the pseudokinase domain in JAK2.

Silvennoinen O, Ungureanu D, Niranjan Y, Hammaren H, Bandaranayake R, Hubbard SR. Silvennoinen O, et al. Biochem Soc Trans. 2013 Aug;41(4):1002-7. doi: 10.1042/BST20130005. Biochem Soc Trans. 2013. PMID: 23863170 Review.

8

Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F.

Bandaranayake RM, Ungureanu D, Shan Y, Shaw DE, Silvennoinen O, Hubbard SR. Bandaranayake RM, et al. Nat Struct Mol Biol. 2012 Aug;19(8):754-9. doi: 10.1038/nsmb.2348. Epub 2012 Jul 22. Nat Struct Mol Biol. 2012. PMID: 22820988 Free PMC article.

9

Structural and thermodynamic basis of amprenavir/darunavir and atazanavir resistance in HIV-1 protease with mutations at residue 50.

Mittal S, Bandaranayake RM, King NM, Prabu-Jeyabalan M, Nalam MN, Nalivaika EA, Yilmaz NK, Schiffer CA. Mittal S, et al. Among authors: bandaranayake rm. J Virol. 2013 Apr;87(8):4176-84. doi: 10.1128/JVI.03486-12. Epub 2013 Jan 30. J Virol. 2013. PMID: 23365446 Free PMC article.

10

Synthesis of bis- and tris-branched COOH-terminal pegylating reagents: conjugation to NH-terminal peptides.

Felix AM, Bandaranayake RM. Felix AM, et al. Among authors: bandaranayake rm. J Pept Res. 2005 Jan;65(1):71-6. doi: 10.1111/j.1399-3011.2005.00206.x. J Pept Res. 2005. PMID: 15686537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page